SCHEMBL5810148

SCHEMBL5810148

Cc1cc2cc(NC(=S)NC(CC(C)C)C(=O)Nc3ccc(C4=NCCN4C)cc3)ccc2o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CAPN1 P07384 7/20 0.40
ALDH1A1 P00352 3/20 0.37
LMNA P02545 1/20 0.37
MAPT P10636 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CA1 P00915 2/20 0.36
CA2 P00918 2/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
F10 P00742 2/20 0.34
KDM4E B2RXH2 2/20 0.34
NPC1 O15118 2/20 0.34
HPGD P15428 2/20 0.34
RAB9A P51151 2/20 0.34
HSD17B10 Q99714 2/20 0.34
MAPK1 P28482 1/20 0.34
TP53 P04637 1/20 0.34
GAA P10253 1/20 0.34
THRB P10828 1/20 0.34
TSHR P16473 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5815855 0.82 KDM4E (0.37) ALDH1A1MAPTSMN1; SMN2F10KDM4E
SCHEMBL5810134 0.80 AAK1 (0.33) ALDH1A1SMN1; SMN2F10KDM4ENPC1
SCHEMBL8264600 0.78 CAPN1 (0.41) CAPN1ALDH1A1LMNAMAPTL3MBTL1
SCHEMBL5912960 0.74 KDM4E (0.35) ALDH1A1SMN1; SMN2F10KDM4ENPC1
SCHEMBL5809930 0.70 F10 (0.42) CAPN1ALDH1A1LMNAMAPTCA1
SCHEMBL5815338 0.66 MEN1 (0.42) ALDH1A1LMNAMAPTCA1CA2
SCHEMBL8265208 0.64 F10 (0.36) ALDH1A1MAPTSMN1; SMN2F10KDM4E
SCHEMBL3562613 0.64 F10 (0.46) MAPTF10
SCHEMBL3567021 0.64 F10 (0.46) MAPTF10
SCHEMBL3562133 0.64 F10 (0.46) MAPTF10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060160790-A1 Thioureas as factor Xa inhibitors PORTOLA PHARMACEUTICALS, INC. (US) 2006-07-20 US claimed
WO-2006063293-A2 THIOUREAS AS FACTOR Xa INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2006-06-15 WO claimed
US-20060160790-A1 Thioureas as factor Xa inhibitors PORTOLA PHARMACEUTICALS, INC. (US) 2006-07-20 US disclosed
WO-2006063293-A2 THIOUREAS AS FACTOR Xa INHIBITORS PORTOLA PHARMACEUTICALS, INC. (US) 2006-06-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060160790-A1 Thioureas as factor Xa inhibitors TFPI, TFPI2, F12 CAPN1 2469/4885ALDH1A1 633/4885LMNA 3071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.